P366: BLINATUMOMAB ADDED TO PREPHASE AND CONSOLIDATION THERAPY IN NEWLY DIAGNOSED PRECURSOR B‐ALL IN ADULTS. A PHASE II HOVON TRIAL

P366: BLINATUMOMAB ADDED TO PREPHASE AND CONSOLIDATION THERAPY IN NEWLY DIAGNOSED PRECURSOR B‐ALL IN ADULTS. A PHASE II HOVON TRIAL

Saved in:
Bibliographic Details
Published in:HemaSphere Vol. 6; pp. 266 - 267
Main Authors: Rijneveld, A., Gradowska, P., Bellido, M., Weerdt, O., Gadisseur, A., Deeren, D., Wagen, L., Jauw, Y., Fijnheer, R., Lammerren, D., Selleslag, D., Halkes, S., Biemond, B., Breems, D., Moors, I., Sluis, G., Bakkus, M., Homburg, C., Janda, V., Velden, V., Cornelissen, J.
Format: Journal Article
Language:English
Published: Philadelphia, PA Lippincott Williams & Wilkins 23-06-2022
Wiley
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
ISSN:2572-9241
2572-9241
DOI:10.1097/01.HS9.0000844352.62588.a4